Weigh Pros and Cons of Palforzia for Peanut Allergy

You’ll hear about Palforzia, the first FDA-approved option for peanut allergy desensitization.

It doesn’t allow patients to freely eat peanut products. But it may minimize an allergic reaction from accidental exposure.

Palforzia is a peanut allergen powder given orally in increasing doses to patients 4 to 17 years old. It’s an alternative to peanut oral immunotherapy already being done by some specialists.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote